A promising “two-in-one” experimental drug could tackle both type 2 diabetes and heart disease by slashing cholesterol and ...

Atorvastatin, one of the world’s most widely prescribed cholesterol-lowering drugs, has played a major role in reducing heart ...

Semaglutide reduces cardiovascular events by 23% and direct heart disease death risk by 26% compared to dulaglutide in older adults.

Researchers say GLP-1 drugs prescribed for weight loss like Ozempic and Mounjaro are more effective at reducing heart health ...

Semaglutide, the active ingredient in Wegovy and Ozempic, lowers major cardiac event risk, regardless of how much weight a ...

Shares of Ventyx Biosciences (NASDAQ:VTYX) continued to climb with a nearly 100% rise in the premarket on Thursday after the ...

A class of drugs called beta-blockers — used for decades as a first-line treatment after a heart attack— doesn’t benefit the vast majority of patients and may contribute to a higher risk of ...

In these cases, starting a statin at a young age can prevent decades of plaque buildup, says Adedapo Iluyomade, MD, a cardiologist at Miami Cardiac & Vascular Institute, Baptist Health South Florida. ...

Building on earlier studies showing its benefits for type 2 diabetes, a new study has revealed the experimental drug IC7Fc ...